The pharmacologic treatment of depression.
This article focuses on the treatment of depression with special reference to pharmacotherapy. The treatment-resistant case and the possible means of resolving its problems are highlighted. The role of ECT will be considered. Long-term maintenance treatment with antidepressant medication for patients with cyclic occurrences is recommended.
D000661:Amphetamine / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003642:Deanol / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008774:Methylphenidate / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010633:Phenmetrazine / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D008996:Monoamine Oxidase Inhibitors; D010880:Piperidines; D008774:Methylphenidate; D003642:Deanol; D008094:Lithium; D000661:Amphetamine; D010633:Phenmetrazine